1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Retinoblastoma Global Clinical Trials Review, H1, 2014

Retinoblastoma Global Clinical Trials Review, H1, 2014

  • April 2014
  • -
  • Global Data
  • -
  • 78 pages

Retinoblastoma Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Retinoblastoma Global Clinical Trials Review, H1, 2014" provides data on the Retinoblastoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Retinoblastoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Retinoblastoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Retinoblastoma Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Retinoblastoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Retinoblastoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Retinoblastoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Retinoblastoma 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Prominent Drugs 30
Latest Clinical Trials News on Retinoblastoma 31
Mar 08, 2013: Cellceutix Announces Positive Preclinical Trial Data Of Kevetrin In Retinoblastoma 31
Jan 11, 2012: Researchers Identify New Genetic Target For Treatment Of Childhood Eye Tumor 31
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Laboratorio Elea S.A.C.I.F. and A 33
Clinical Trial Overview of Laboratorio Elea S.A.C.I.F. and A 33
Clinical Trial Overview of Top Institutes / Government 34
National Cancer Institute 34
Clinical Trial Overview of National Cancer Institute 34
Children's Oncology Group 35
Clinical Trial Overview of Children's Oncology Group 35
Memorial Sloan Kettering Cancer Center 36
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 36
Hadassah Medical Organization 37
Clinical Trial Overview of Hadassah Medical Organization 37
Stanford University 38
Clinical Trial Overview of Stanford University 38
The University of Texas M. D. Anderson Cancer Center 39
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 39
All India Institute of Medical Sciences 40
Clinical Trial Overview of All India Institute of Medical Sciences 40
Sun Yat-sen University 41
Clinical Trial Overview of Sun Yat-sen University 41
Cincinnati Children's Hospital Medical Center 42
Clinical Trial Overview of Cincinnati Children's Hospital Medical Center 42
Five Key Clinical Profiles 43
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 78

List of Tables
Retinoblastoma Therapeutics, Global, Clinical Trials by Region, 2014* 7
Retinoblastoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Retinoblastoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Retinoblastoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Retinoblastoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Retinoblastoma Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Retinoblastoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Retinoblastoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Retinoblastoma to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Retinoblastoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Retinoblastoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Retinoblastoma to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Retinoblastoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Retinoblastoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Retinoblastoma Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Retinoblastoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Retinoblastoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Retinoblastoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Retinoblastoma Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Retinoblastoma Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Retinoblastoma Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Retinoblastoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Retinoblastoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 28
Retinoblastoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 29
Retinoblastoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratorio Elea S.A.C.I.F. and A, 2014* 33
Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 34
Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Oncology Group, 2014* 35
Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 36
Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 37
Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 38
Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014* 39
Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by All India Institute of Medical Sciences, 2014* 40
Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014* 41
Retinoblastoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cincinnati Children's Hospital Medical Center, 2014* 42

List of Figures
Retinoblastoma Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Retinoblastoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Retinoblastoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Retinoblastoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Retinoblastoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Retinoblastoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Retinoblastoma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Retinoblastoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Retinoblastoma to Oncology Clinical Trials, G7 Countries (%), 2014* 15
Retinoblastoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Retinoblastoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Retinoblastoma to Oncology Clinical Trials, E7 Countries (%), 2014* 18
Retinoblastoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Retinoblastoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Retinoblastoma Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Retinoblastoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Retinoblastoma Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Retinoblastoma Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Retinoblastoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 27
Retinoblastoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 28
Retinoblastoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30
GlobalData Methodology 76

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.